台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼0.5
  • 漲幅
    -0.50%
  • 成交量
    63
  • 產業
    上櫃 文化創意指數
  • 106人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
智基 (6294)籌碼相關-元大-桃興 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-桃興 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/140.1103.500.1101.00102.0001440.00%
2024/05/1300.000.8107.00107.00-0.8127-0.63%
2024/05/090.1119.0000.00118.500.11190.08%
2024/04/190.4116.0000.00116.000.41130.35%
2024/04/170.1117.0000.00117.000.11110.09%
2024/04/161113.0000.00114.0011110.90%
2024/04/101126.503.1126.50127.00-2.195-2.19%
2024/04/020.1123.0000.00123.500.1700.14%
2024/03/2200.001124.00122.50-160-1.66%
2024/03/201121.5000.00121.501561.77%
2024/03/180.1124.0000.00124.000.1510.20%
2024/01/0900.000.2112.00112.50-0.227-0.54%
2023/11/2400.000.2113.00112.50-0.220-0.96%
2023/11/100.1114.0000.00113.500.1200.25%
2023/10/1200.001116.50117.00-125-3.96%
2023/09/081113.5000.00113.501273.61%
2023/08/0700.002111.50111.00-230-6.52%
2023/06/211108.5000.00108.001521.91%
2023/06/150.1108.0000.00109.000.1550.09%
2023/05/1200.000.1106.50106.50-0.155-0.26%
2023/05/110.1107.000.3106.50106.50-0.155-0.19%
2023/04/2600.001108.00108.50-153-1.89%
2023/04/250.1109.0000.00109.000.1520.09%
2023/04/240.1109.0000.00109.000.1530.19%
2023/04/1700.001111.00109.50-151-1.95%
2023/04/131118.5000.00119.501472.09%
2023/04/122118.5000.00119.002424.70%
2023/04/110.1120.0000.00121.000.1400.25%
2023/03/160.1112.5000.00112.000.1270.18%
2023/02/1600.000.1108.00108.00-0.137-0.27%
2022/07/060.197.0000.0097.100.1440.23%
2022/05/180.199.0000.0097.900.1430.23%
2022/04/2200.000.1124.00124.00-0.125-0.39%
2022/04/140.1126.0000.00126.000.1250.40%
2022/03/2100.001131.50132.00-119-5.20%
2022/03/100.1125.0000.00126.000.1220.22%
2022/02/101127.0000.00127.001214.67%
2022/01/2600.000125.00124.00021-0.11%
2021/12/080.3125.5000.00125.500.3280.86%
2021/12/071125.0000.00125.001283.45%
2021/09/100.1142.0000.00143.500.1340.33%
2021/07/0700.000.1152.50152.50-0.135-0.28%
2021/06/100.1150.0000.00151.500.1460.22%
2021/05/1200.001141.50142.00-144-2.23%
2021/05/0400.001143.50143.00-139-2.52%
2020/09/211110.5000.00110.501372.64%
2020/07/2400.003106.50106.50-363-4.73%
2020/06/291107.5000.00107.501621.61%
2020/06/233114.5000.00115.003575.26%
2020/06/101114.0000.00114.001531.88%
2020/06/0800.001114.00113.50-156-1.76%
2020/04/08198.8000.0098.801422.33%
2020/03/300.194.5000.0094.500.1410.24%
2020/03/270.195.8000.0095.000.1410.12%
2020/03/24192.3000.0094.001392.56%
2020/03/1300.00893.1995.10-833-24.13%
2020/03/12198.1000.0098.101303.33%
2020/03/091100.0000.00100.001273.63%
2020/02/213100.5000.00101.5032611.47%
2020/02/201100.5000.00100.501253.89%
2020/02/111101.0000.00101.001263.72%
2020/02/071101.0000.00101.001273.67%
2019/11/040.1102.0000.00102.500.1210.46%
2019/07/041102.5000.00102.001442.24%
2019/07/030.1103.5000.00103.000.1440.22%
2019/05/130.1107.0000.00106.500.1420.23%
2019/04/250.1109.0000.00109.500.1390.25%
2019/03/220.1111.5000.00111.000.1300.32%
2019/03/0600.000.2109.00109.00-0.225-0.78%
2019/02/200.1108.0000.00108.500.1230.43%
2018/11/2700.000.1102.50104.00-0.128-0.19%
2018/11/0100.001100.50102.00-129-3.42%
2018/10/25199.0000.0099.601303.27%
2018/08/0700.001111.00112.50-163-1.58%
2018/08/0600.001112.50113.00-164-1.55%
2018/07/2400.001125.50126.00-184-1.18%
2018/07/191125.5000.00125.501831.20%
2018/07/091124.0000.00124.001851.16%
2018/06/2200.001124.50125.50-195-1.04%
2018/05/1500.001125.00126.00-1128-0.78%
2018/04/301125.5000.00125.5011150.87%
2018/04/2500.001122.50123.00-1134-0.74%
2018/04/091128.0000.00127.0011640.61%
2018/03/191128.0000.00127.5011760.57%
2018/03/1500.0010122.00122.50-10168-5.94%
2018/03/1400.003121.00121.50-3171-1.75%
2018/03/1200.003120.50120.00-3171-1.74%
2018/03/0900.004120.00120.00-4172-2.32%
2018/03/0800.000.1119.50119.50-0.1171-0.04%
2018/03/0700.001119.00118.50-1175-0.57%
2018/03/0100.002118.50118.00-2172-1.16%
2018/02/2700.003117.00117.00-3172-1.74%
2018/02/2600.0010119.60116.50-10172-5.80%
2018/02/021121.501123.50123.0001630.00%
2018/01/251125.501123.50123.5001610.00%
2018/01/231123.0000.00123.0011550.64%
2018/01/0400.002112.50112.00-298-2.04%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音